Panacea Innovation Ltd → Atara Biotherapeutics, Inc. ATRA

Stake: — Shares: 1,318,894 Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-04-30

DTC 6.10

306,093 shares short · -3.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $331K

Point72 Asset Mgmt

Other 13D/G Filings on Atara Biotherapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-05-14	SCHEDULE 13D/A	Redmile Group, LLC	9.90%	950,994	view →

Other Filings by Panacea Innovation Ltd

Filed	Form	Issuer	Stake	Shares
2026-04-01	SCHEDULE 13D/A	Connect Biopharma Holdings Limited CNTB	21.20%	13,160,000	view →
2025-07-21	SCHEDULE	Connect Biopharma Holdings Ltd CNTB	25.10%	13,950,000	view →
2024-07-01	SC	Connect Biopharma Holdings Ltd CNTB	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →